Ataxia Centre news

Professor Paola Giunti has won the Impactful Partnership with Industry award at UCL's Creating Impact Through Knowledge Exchange Awards 2025 announced yesterday at Senate House

Neurological signs and symptoms of the different subgroups of a rare condition, called xeroderma pigmentosum (XP), have been systematically characterised for the first time by researchers at the UCL A

We are delighted to announce that the Ataxia Centre, UCL Queen Square Institute of Neurology, is the first & only centre in the UK to receive the accreditation

A multi-disciplinary team of researchers, including Professor Paola Giunti and Dr Suran Nethisinghe at the UCL Ataxia Centre, UCL Queen Square Institute of Neurology, have developed a way to monitor the progression of Friedreich's ataxia using motion capture technology and AI.

We are delighted to announce that Professor Paola Giunti's trial about Friedreich Ataxia, MOXIe Part II, was FDA inspected in August 2022 at the Leonard Wolfson Experimental Neurology Centre (LWENC) and was assessed as outstanding.

Dr Garcia-Moreno, a Neurologist & Clinical Research Fellow working at the Ataxia Centre, UCL Queen Square Institute of Neurology, in the team led by Professor Paola Giunti, recently published a journal article about their work identifying biomarkers for SCA3

Researchers at Ataxia Centre, UCL Queen Square Institute of Neurology, UCLH, Children’s Hospital of Philadelphia, Ataxia UK and Friedreich’s Ataxia Research Alliance (FARA) have published research looking at the attitudes of people with ataxia towards clinical trials.

Interview with researcher Dr Suran Nethisinghe on a new paper on Friedreich’s ataxia (FA) from the team led by Professor Paola Giunti at the London Ataxia Centre, UCL Queen Square Institute of Neurology

Professor Paola Giunti (Head of London Ataxia Centre, UCL Queen Square Institute of Neurology) presented the preliminary results of a project on ataxia to the European Brain Council (EBC), as one of three rare diseases included in the ‘Value of Treatment’ (VOT) project.

UCL Queen Square Institute of Neurology is pleased to report on its second inaugural lecture evening of 2019, held on 1st April 2019

A new study by researchers at UCL Queen Square Institute of Neurology could help to understand the lack of balance that arises from brain diseases and normal ageing.

Ataxia UK updated and expanded Medical Guidelines were produced to help healthcare professionals in the diagnosis and management of people with ataxia

Vitamin E could help prevent death caused by heart failure in patients who suffer from a rare neurological and cardiac disorder, a new UCL-led study has found.